Clinical Perspectives

New Tools and Techniques for Improved Surgical Outcomes for Patients with Brain Tumors

The goals of brain tumor surgery are to obtain tissue for diagnosis/classification and remove as much of the bulk tumor as possible. One of the key...

The Utility of Trastuzumab Monotherapy in HER2+ Breast Cancer

Older cancer patients who are reluctant to receive chemotherapy could be effectively treated with trastuzumab monotherapy without significantly...

Endometrial Cancer: Routes of Surgery

"Minimally invasive surgery should be embraced as the standard surgical approach for comprehensive staging in women with endometrial cancer," says...

Virtual Cancer Care Enhances Our Patient Experience

The virulent spread of COVID-19 throughout the country over a year and a half ago has resulted in an urgent mandate for the utilization of...

New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients

Moffitt is one of a few hospitals nationwide testing ALLO-501a, an allogeneic CAR T therapy product from Allogene Therapeutics, in combination with...

Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver

Moffitt Cancer Center is leading the research in rare sarcomas and has performed the most comprehensive molecular analysis to-date of...

Percutaneous Hepatic Perfusion in Patients with Hepatic-dominant Ocular Melanoma

The analysis indicated that PHP demonstrated a statistically superior overall response rate and significantly prolonged progression-free survival in...

GRECO-2 Trial Could Show Promising Results for Pancreatic Cancer

Moffitt was one of the high-volume centers with the last trial, which showed improved outcomes. Moffitt researchers are hopeful that this current...

TVEC for the Treatment of Early Stage Triple Negative Breast Cancer

TVEC is designed to preferentially lyse tumor cells over normal tissue to release tumor associated antigens, produces GM-CSF to activate dendritic...

Reshaping the Frontline Treatment Landscape of ES-SCLC

Dr. Bruna Pellini, in an interview with OncLive®, also compares the findings of the CASPIAN and IMpower133 trials and research efforts currently...

Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs

With recent screening guidelines changes, more people are eligible for a low-dose CT scan and have the ability to participate in lung screening...

Macrophage Tumor Cell Metabolic Interactions Induce Therapeutic Resistance in Prostate Cancer

Castration-resistant prostate cancer (CRPC) is a lethal stage of disease. A wealth of clinical and experimental data supports the persistence of...

In Silico Trial Estimates Personalized Radiation Therapy Dose in Head and Neck Cancer

By means of this unique in silico trial, we demonstrate a potential method to use historical clinical observations in conjunction with...

Circulating tumor DNA (ctDNA) MRD Detection from Plasma and Urine and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer

Tumor-naïve plasma ctDNA analysis can sensitively and specifically detect MRD in patients with oligometastatic CRC after neoadjuvant chemotherapy....

Pushing for a Cure: New Treatments for Head and Neck-Endocrine Cancer

Moffitt's Head and Neck-Endocrine Oncology Department discuss new treatments for Head and Neck and Endocrine cancers in this webinar and Q&A session.